Comparison between Gradient Gel Electrophoresis and Nuclear Magnetic Resonance Spectroscopy in Estimating Coronary Heart Disease Risk Associated with LDL and HDL Particle Size

被引:32
|
作者
Arsenault, Benoit J. [2 ,3 ]
Lemieux, Isabelle [3 ]
Despres, Jean-Pierre [3 ,4 ]
Wareham, Nicholas J. [5 ]
Stroes, Erik S. G. [2 ]
Kastelein, John J. P. [2 ]
Khaw, Kay-Tee [6 ]
Boekholdt, S. Matthijs [1 ,2 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands
[3] Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
[4] Univ Laval, Div Kinesiol, Dept Social & Prevent Med, Quebec City, PQ, Canada
[5] Med Res Council Epidemiol Unit, Cambridge, England
[6] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
LOW-DENSITY-LIPOPROTEIN; MYOCARDIAL-INFARCTION; EPIC-NORFOLK; ATHEROGENIC DYSLIPIDEMIA; CARDIOVASCULAR RISK; CHOLESTEROL; PLASMA; MANAGEMENT; OBESITY; MEN;
D O I
10.1373/clinchem.2009.140939
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Gradient gel electrophoresis (GGE) and nuclear magnetic resonance (NMR) spectroscopy are both widely accepted methods for measuring LDL and HDL particle size. However, whether or not GGE- or NMR-measured LDL or HDL particle size predicts coronary heart disease (CHD) risk to a similar extent is currently unknown. METHODS: We used GGE and NMR to measure LDL and HDL particle size in a nested case-control study of 1025 incident cases of CHD and 1915 controls from the EPIC (European Prospective Investigation into Cancer and Nutrition)-Norfolk study. The study sample included apparently healthy men and women age 45-79 years followed for an average of 6 years. RESULTS: Pearson correlation coefficients showed that the overall agreement between NMR and GGE was better for the measurement of HDL size (r = 0.78) than for LDL size (r = 0.47). The odds ratio for future CHD among participants in the bottom tertile of LDL size (smallest LDL particles) was 1.35 (95% CI, 1.12-1.63) for GGE and 1.74 (1.41-2.15) for NMR. For HDL size, these respective odds ratios were 1.41 (1.16-1.72) and 1.85 (1.47-2.32). After adjustment for potential confounders, the relationship between small LDL or HDL particles and CHD was no longer significant, irrespective of the method. CONCLUSIONS: In this prospective population study, we found that the relationships between NMR-measured LDL and HDL sizes and CHD risk were slightly higher than those obtained with GGE. (C) 2010 American Association for Clinical Chemistry
引用
收藏
页码:789 / 798
页数:10
相关论文
共 21 条
  • [1] Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis
    Witte, DR
    Taskinen, MR
    Perttunen-Nio, H
    van Tol, A
    Livingstone, S
    Colhoun, HM
    JOURNAL OF LIPID RESEARCH, 2004, 45 (06) : 1069 - 1076
  • [2] Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study
    Kuller, L
    Arnold, A
    Tracy, R
    Otvos, J
    Burke, G
    Psaty, B
    Siscovick, D
    Freedman, DS
    Kronmal, R
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (07) : 1175 - 1180
  • [3] Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?
    Zeljkovic, Aleksandra
    Spasojevic-Kalimanovska, Vesna
    Vekic, Jelena
    Jelic-Ivanovic, Zorana
    Topic, Aleksandra
    Bogavac-Stanojevic, Natasa
    Spasic, Slavica
    Vujovic, Ana
    Kalimanovska-Ostric, Dimitra
    CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 8 (02) : 109 - 116
  • [4] Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?
    Aleksandra Zeljkovic
    Vesna Spasojevic-Kalimanovska
    Jelena Vekic
    Zorana Jelic-Ivanovic
    Aleksandra Topic
    Natasa Bogavac-Stanojevic
    Slavica Spasic
    Ana Vujovic
    Dimitra Kalimanovska-Ostric
    Clinical and Experimental Medicine, 2008, 8 : 109 - 116
  • [5] Risk of angiographically-assessed coronary artery disease associated with LDL and HDL particle sizes in women
    Blackburn, P.
    Lemieux, I.
    Lamarche, B.
    Bergeron, J.
    Perron, P.
    Tremblay, G.
    Gaudet, D.
    Despres, J. P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 475 - 475
  • [6] First Demonstration that Lower LDL/ApoB Ratio Strongly Correlates with LDL Particle Size Measured by Gradient Gel Electrophoresis and Predicts Coronary Artery Calcification
    Marvasty, Idean B.
    Rinehart, Sarah
    Tekleyes, Fikadu
    Miller, Joseph
    LeStrange, Renee
    Vazquez, Jesus G.
    Qian, Zhen
    Kalynych, Anna
    Brown, Charlie
    Voros, Szilard
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E102 - E102
  • [7] Non-HDL cholesterol, ApoB and LDL particle concentration in coronary heart disease risk prediction and treatment
    Orringer, Carl E.
    CLINICAL LIPIDOLOGY, 2013, 8 (01) : 69 - 79
  • [8] TWO-DIMENSIONAL GRADIENT GEL ELECTROPHORESIS OF HDL AND SMALL DENSE LDL, REVEAL BEHAVIORAL-RELATED HEART DISEASE RISK IMPROVEMENTS MISSED BY THE TRADITIONAL HDL-C AND LDL-C MEASUREMENTS
    Superko, H. Robert
    Gill, Rosalynn
    McCarthy, Megan
    Jack, Kepra
    Ghosh, Debanjali
    Jones, Briana E.
    Gleason, Joi
    Williams, Paul T.
    Dansinger, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1770 - 1770
  • [9] Coronary artery endothelial dysfunction is associated with LDL- and HDL-lipoprotein subclasses measured by nuclear magnetic spectroscopy
    Ford, Monique A.
    McConnell, Joseph
    Hartman, Stacy J.
    Lavi, Shahar
    Lerman, Lilach O.
    Lerman, Amir
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E82 - E82
  • [10] LDL particles (LDLP), small LDL particles (SLDLP), and LDL size by nuclear magnetic resonance (LDS-NMR) are more related to metabolic syndrome (MetS) components than are APOB and LDL size by gradient gel electrophoresis (LDLS-GGE)
    Haffner, S
    Williams, K
    Festa, A
    Hanley, A
    DIABETES, 2005, 54 : A1 - A1